Dr. Nicholas Conley is an Angel Investor. He Co-Founded and served as Chief Science Officer & Board Member at EpiBiome. He is an Angel Investor. He completed a PhD in Chemistry and a postdoctoral fellowship in Developmental Biology at Stanford University, where he trained as a synthetic chemist and molecular biologist. Dr. Conley possesses a direct Nobel Laureate pedigree, having worked with Prof. W. E. Moerner at Stanford University, winner of the 2014 Nobel Prize in Chemistry. Dr. Conley was a Beckman Fellow, a National Science Foundation Graduate Research Fellow, a Lieberman Fellow, a Stanford Molecular Imaging Scholars Fellow, and a Younger Fellow. He has published 18 peer-reviewed journal articles on topics including palladium catalysis, super-resolution fluorescence imaging, single-molecule DNA detection, and cancer biology, and he holds four U.S. patents. Prior to founding EpiBiome, Dr. Conley was a Research Staff Member at HGST, a Western Digital Company.